Device Dx - Diagnostics Incl. All Products and Services

Dimension Exl With Lm

Payments companies reported to CMS as associated with Dimension Exl With Lm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$11Kassociated payments (2023-2025)
15clinicians with associated payments
1company reporting

By year

2023 $220
2025 $11K

Payments reported as associated with Dimension Exl With Lm, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $5,834
Internal Medicine $1,953
Behavioral Neurology & Neuropsychiatry $312
Anatomic Pathology & Clinical Pathology $173
Clinical Pathology/Laboratory Medicine $156
General Practice $20.33

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dimension Exl With Lm

These are the largest totals companies reported as associated with Dimension Exl With Lm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Justin Long Saint Louis, MO Neurology (Psychiatry & Neurology) $3,636.48
Anne Hiniker Los Angeles, CA $2,774.49
Lawren Vandevrede Boston, MA Internal Medicine $1,924.42
Navid Seraji Bozorgzad Ann Arbor, MI Neurology (Psychiatry & Neurology) $1,019.05
Michael Racke Columbus, OH Neurology (Psychiatry & Neurology) $822.74
Oleg Yerstein Burlington, MA Neurology (Psychiatry & Neurology) $355.34
William Hu New Brunswick, NJ Behavioral Neurology & Neuropsychiatry $312.34
Petr Jarolim Boston, MA Clinical Pathology/Laboratory Medicine $156.34
Jason Loos Lubbock, TX Anatomic Pathology & Clinical Pathology $126.63
Heather Dryden Saint Helens, OR Internal Medicine $28.33

Prescribed Dimension Exl With Lm?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.